Boston Scientific Corp Company News
DENTSPLY SIRONA's (XRAY) first-quarter 2024 results showcase a decline in year-over-year sales with an improved bottom line.
Each of Zimmer Biomet's (ZBH) geographic segments records strong year-over-year sales growth on a reported basis, as well as at CER.
Envista (NVST) registers a year-over-year decline in both segments in the first quarter of 2024.
Investors are optimistic about Quest Diagnostics (DGX) on strong legacy business growth.
Cardinal Health's (CAH) third-quarter fiscal 2024 results benefit from solid profit growth in Pharmaceutical and Specialty Solutions. The company raises its EPS guidance for fiscal 2024.
Baxter (BAX) reports better-than-expected first-quarter earnings and sales. BAX's quarterly results reflect solid demand for a range of its medically essential products.
BD's (BDX) overall top line benefits from revenue growth in all segments and both geographic regions in the fiscal second quarter.
Despite strength in radiation oncology, Accuray (ARAY) reports dismal third-quarter fiscal 2024 results.
Glaukos' (GKOS) first-quarter 2024 results showcase growth in revenues while earnings miss the Zacks consensus Estimate. Loss at the operating level raises concern as well.
Merit Medical (MMSI) benefits from revenue growth in both segments and the majority of its product categories within its Cardiovascular unit in the first quarter.
CVS Health's (CVS) Q1 performance is impacted by a decline in the Health Services segment due to continued pharmacy client price improvements.
Inari Medical's (NARI) first-quarter results witness an increase in revenues with dismal bottom-line performance. Gross margins contract while the companies continue to incur operating losses.
Cencora's (COR) second-quarter fiscal 2024 results benefit from overall market growth, including rising demand for GLP-1 drugs and COVID-19 vaccines. Inflationary pressure remains.
Boston Scientific Corporation (BSX) shares are up 25% so far in 2024. Looking under the surface, it’s clear to see why this medical technology stock is gaining.
Ecolab's (ECL) robust performance across the majority of its segments drives its first-quarter sales despite business challenges.
Old Arcived News About Boston Scientific Corp
- 3 Things to Know Before Selling Boston Scientific Group (BSX).
- 4:17 pm Boston Scientific receives FDA approval and CE Mark for its the AngioJet ZelanteDVT thrombectomy catheter to treat deep vein thrombosis.
- Baxter, With Loeb, Adds Boston Scientific CEO to Board.
- Bears taking aim at Boston Scientific.
- Boston Scientific (BSX) Earnings Report: Q4 2015 Conference Call Transcript.
- Boston Scientific (BSX) Leads The Pack In Pre-Market Activity.
- Boston Scientific (BSX) Stock Declining After Earnings Results.
- Boston Scientific (BSX) Stock Falling Ahead of Q4 Earnings Release.
- Boston Scientific CEO to Add Chairman Title as Nicholas Retires.
- BOSTON SCIENTIFIC CORP Financials.
- Boston Scientific Experiments to Find Growth.
- Boston Scientific Falls 4.2% on Coverage Issues.
- Boston Scientific Gets CE Mark for New WATCHMAN Device.
- Boston Scientific Lost the First Place in Innovation.
- Boston Scientific Receives CE Mark For Next Generation WATCHMAN FLXâ„¢ Left Atrial Appendage Closure Device. [at noodls] - MARLBOROUGH, Mass., Nov. 19, 2015 /PRNewswire/ -- Boston Scientific (NYSE: BSX) today announced that the first implants of the WATCHMAN FLXâ„¢ Left Atrial Appendage Closure (LAAC) Device - the latest generation ...
- Boston Scientific Receives FDA Approval And CE Mark For AngioJetâ„¢ ZelanteDVTâ„¢ Thrombectomy Catheter. [at noodls] - MARLBOROUGH, Mass., Nov. 30, 2015/PRNewswire / -- Boston Scientific (NYSE: BSX) has received United States(U.S.) Food and Drug Administration (FDA) approval and CE Mark for the AngioJetâ„¢ ZelanteDVTâ„¢ thrombectomy ...
- Boston Scientific Scores Perfect 100 on Human Rights Campaign's 2016 Corporate Equality Index. [PR Newswire] - MARLBOROUGH, Mass., Nov. 18, 2015 /PRNewswire/ -- Boston Scientific (BSX) has received a score of 100 percent on the 2016 Corporate Equality Index (CEI), a national benchmarking survey and report on corporate policies and practices related to lesbian, gay, bisexual and transgender (LGBT) workplace equality, administered by the Human Rights Campaign Foundation. "We are very proud to have again earned top marks in the Corporate Equality Index," said Dan Brennan, executive vice president and chief financial officer, Boston Scientific, and chair of the company's Global Council for Inclusion.
- Boston Scientific Stable in Core Markets, Currency Woes Stay.
- Boston Scientific To Participate In 33rd Annual J.P. Morgan Healthcare Conference. [at noodls] - Dec 22, 2014 MARLBOROUGH, Mass. , Dec. 22, 2014 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) is scheduled to participate in the 33rd Annual J.P. Morgan Healthcare Conference on Tuesday, January ...
- Boston Scientific To Participate In Goldman Sachs CEOs Unscripted Healthcare Conference. [at noodls] - Dec 18, 2014 MARLBOROUGH, Mass. , Dec. 18, 2014 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) is scheduled to participate in the Goldman Sachs CEOs Unscripted Healthcare Conference on Tuesday, ...
- Boston Scientific To Participate In Oppenheimer 2015 Healthcare Conference. [at noodls] - MARLBOROUGH, Mass., Nov. 24, 2015/PRNewswire / -- Boston Scientific Corporation (NYSE: BSX) is scheduled to participate in the Oppenheimer 26th Annual Healthcare Conference on December 8, in New York City. ...
- Boston Scientific To Participate In Piper Jaffray 2015 Healthcare Conference. [at noodls] - MARLBOROUGH, Mass., Nov. 17, 2015/PRNewswire / -- Boston Scientific Corporation (NYSE: BSX) is scheduled to participate in the Piper Jaffray 27th Annual Healthcare Conference on December 1, in New York ...
- Boston Scientific to Sell ZelanteDVT Catheter in US, Europe.
- Here’s Why Boston Scientific (BSX) Stock is Rising Today.
- Insider Selling Alert at East West Bancorp Inc..
- Insider Trading Alert - BSX, PGC And BANR Traded By Insiders.
- Insider Trading Alert - BSX, PRO And UVV Traded By Insiders.
- IPO Stock Watch: Medical Device Maker Nevro Hits High.
- Medtronic Delivering Shareholder Value Ahead.
- New Data Presented At NANS 2014 Demonstrate Long-Term, Low Back Pain Relief With Boston Scientific Precision Spectraâ„¢ Spinal Cord Stimulator System. [at noodls] - Significant Relief Achieved Using Advanced Illuminaâ„¢ 3D Programming Software Dec 12, 2014 MARLBOROUGH, Mass. , Dec. 12, 2014 /PRNewswire/ -- New retrospective data evaluating the Boston Scientific Corporation ...
- Omega Advisors eliminates position in Boston Scientific.
- Puts surging in Boston Scientific.
- Trade-Ideas: Boston Scientific (BSX) Is Today's Post-Market Leader Stock.
- Trade-Ideas: Boston Scientific (BSX) Is Today's Unusual Social Activity Stock.
- Volcano Up 55% On Acquisition News.
- What Traders Look in a Chart - Research on Boston Scientific, TRI Pointe Group, TherapeuticsMD, and Media General. [Accesswire] - NEW YORK, NY / ACCESSWIRE / December 9, 2015 / Moments ago, Trader's Choice released new research updates concerning several important developing situations including the following equities: Boston Scientific ...
Boston Scientific Corp Short Company Overview:
Boston Scientific Corporation develops, manufactures, and markets minimally invasive medical devices. The Company's products are used in interventional cardiology, cardiac rhythm management, peripheral interventions, electrophysiology, neurovascular intervention, endoscopy, urology, gynecology and neuromodulation.
